A role for insulin resistance in mediating the interplay between eotaxin and other inflammation/immune parameters could be evidenced in the induction/maintenance of atherosclerosis of obese patients with NAFLD. Here, CCL11 is linked to metabolic dysfunction-associated steatotic liver disease.